1) Spector, A. R., Gray, A. and Prien, E. L. Jr.: Kidney stone matrix: Differences in acidic protein composition. Invest. Urol., 13, 387-389, 1976.
2) Lian, J. B., Prien, E. L. Jr., Glimcher, M. J. and Gallop, P. M.: The presence of protein-bound γ-carboxyglutamic acid in calcium-containing renal calculi. J. Clin. Invest., 59, 1151-1157, 1977.
3) Warpehoski, M. A., Buscemi, P. J., Osborn, D. C., Finlayson, B. and Goldberyg, E. P.: Distribution of organic matrix in calcium oxalate renal calculi. Calcif. Tissue Int., 33, 211-222, 1981.
4) Sugimoto, T., Funae, Y., Rübben, H., Nishio, S., Hautmann, R. and Lutzeyer, W.: Resolution of proteins in the kidney stone matrix using high-performance liquid chromatography. Eur. Urol., 11, 334-340, 1985.
5) Nakagawa, Y., Ahmed, M. A., Hall, S. L., Deganello, S. and Coe, F. L.: Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. -Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in γ-carboxyglutamic acid. J. Clin. Invest., 79, 1782-1787, 1987.